Nuclear Medicine in Belgium

14 – 15 Oct 2026 | Suarlée, Belgium

HomeAgendaParticipantsMarketplace
Register
Register
Register

Thursday, 15 October 2026 | 15:10 - 16:30

Thematic session 4 – From promise to impact: How innovations successfully scale and reach patients

Location:Salle ImpressionnisteTrack:Regional Strengths & National Leadership
  • Nuclear medicine
  • Radioligand therapy (RLT)
  • Radiotheranostics
  • Oncology
  • Precision medicine
  • Health innovation
  • Clinical innovation
  • Patient impact
  • Innovation ecosystem
  • Scaling innovation
  • Public-private partnerships
  • Academic-industry collaboration
  • Market access
  • Belgian excellence

This session will showcase Belgium’s excellence in nuclear medicine through concrete examples of innovation transforming clinical practice.

Key highlights include:

  • Three compelling success stories from leading Belgian actors

  • The development of breakthrough therapies and enabling technologies

  • The role of novel radioisotopes in advancing the field

  • How innovation moves from concept to clinical application

  • The tangible and measurable impact on patients

The session will also emphasize:

  • The strength and complementarity of the Belgian ecosystem

  • A broader view of national capabilities in nuclear medicine

It will conclude with:

  • A high-level roundtable gathering C-level leaders

  • A strategic discussion on how to sustain and strengthen

  • Belgium’s global leadership in a fast-evolving, competitive landscape

Why attend?

Understand how local excellence can drive global impact, and identify the key conditions needed to turn innovation into meaningful patient outcomes.

1 speaker

  • CEO

    PanTera nv